Injection of Phosphatidylcholine in Fat Tissue: Experimental Study of Local Action in Rabbits

@article{Rittes2005InjectionOP,
  title={Injection of Phosphatidylcholine in Fat Tissue: Experimental Study of Local Action in Rabbits},
  author={Patr{\'i}cia Guedes Rittes and Jos{\'e} Carlos Rittes and Maria Fernanda Carriel Amary},
  journal={Aesthetic Plastic Surgery},
  year={2005},
  volume={30},
  pages={474-478}
}
BackgroundsSubcutaneous phosphatidylcholine to cause local lipolysis has been performed effectively and safely in the nonsurgical treatment of periorbital fat pads and also in the treatment of localized fat deposits in the abdomen, neck, arms and thighs. However, the studies do not explain the mechanism through which injectable phosphatidylcholine causes localized fat reduction. This study aimed to compare the local action of a phosphatidylcholine formulation with that of a physiologic saline… 
View on Springer
ncbi.nlm.nih.gov
41 Citations
Background Citations
6
Results Citations
2

41 Citations

Citation Type

Citation Type

The Effect of Phosphatidylcholine and Deoxycholate Compound Injections to the Localized Adipose Tissue: An Experimental Study with a Murine Model
TLDR
The efficacy of the PPC dissolved in DCA via an experimental rat study model is discussed, along with suggesting a useful animal experimental model for the study of adipose tissue and lipolysis and recommending the rat inguinal fat pad model, as it is likely to be useful in related research.
Tissue‐Toxic Effects of Phosphatidylcholine/Deoxycholate after Subcutaneous Injection for Fat Dissolution in Rats and a Human Volunteer
TLDR
Injection lipolysis with PC/DC causes tissue fibrosis and necrosis of adipose and vascular tissues in rat and man, making the long-term safety of PC/ DC for nonsurgical treatment of subcutaneous fat deposits uncertain.
Phosphatidylcholine and Sodium Deoxycholate in the Treatment of Localized Fat: A Double‐Blind, Randomized Study
TLDR
Both treatments have shown moderate and equivalent efficacy in treating localized fat, with sodium deoxycholate having a slower postoperative resolution, suggesting that sodium de oxygencholate could be sufficient by itself to determine fat cell destruction and that phosphatidylcholine could be useful for obtaining a later emulsification of the fat.
Histological changes after treatment for localized fat deposits with phosphatidylcholine and sodium deoxycholate
TLDR
Important microscopic evidence of substitution of fat by fibrosis, marked inflammatory infiltration with microabscess formation in the dermis, and septal and lobular panniculitis with thick fibrous septa is observed in the subcutaneous fat following PPC and DC injections.
Histopathological and ultra-structural characterization of local neuromuscular damage induced by repeated phosphatidylcholine/deoxycholate injection.
Evaluation of Safe and Effectiveness of an Injectable Solution Acid Deoxycholic Based for Reduction of Localized Adiposities
TLDR
Studies have shown that the second-generation solution containing sodium deoxycholate 1.25% is effective and safe to treat different localized fat deposits and was not associated with a lesser degree of handling.
A New Method to Quantify the Effect After Subcutaneous Injection of Lipolytic Substances
TLDR
The data suggest that RT-3D ultrasound imaging could be a simple and fast method for proving the effects on volume size after lipolytic procedures, and orciprenalin (Alupent®) showed the highestlipolytic effect in the authors' animal model.
Compounds Used for ‘Injection Lipolysis’ Destroy Adipocytes and other Cells Found in Adipose Tissue
TLDR
Applying injection lipolysis with phosphatidylcholine as the major injected compound reduces subcutaneous fat pad size through cell and tissue destruction represents off-label drug use and application of a drug by a contraindicated route.
Refinement of technique in injection lipolysis based on scientific studies and clinical evaluation.
The Role of Fat Reducing Agents on Adipocyte Death and Adipose Tissue Inflammation
TLDR
A PubMed search and review of articles integrated the findings of this growing body of literature into a proposed mechanism of fat reduction and provides direction for further studies.
...
...

References

SHOWING 1-9 OF 9 REFERENCES
Treatment of Lower Eyelid Fat Pads Using Phosphatidylcholine: Clinical Trial and Review
  • G. Ablon, A. Rotunda
  • Medicine
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
  • 2004
TLDR
Injectable phosphatidylcholine is a novel treatment for infraorbital fat herniation that may benefit some patients who are considering blepharoplasty and larger studies evaluating long-term safety and efficacy of phosphatin-derived phospholipid for cosmetic purposes are warranted.
Histological changes associated with mesotherapy for fat dissolution
  • P. Rose, M. Morgan
  • Medicine
    Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology
  • 2005
TLDR
It is demonstrated that mesotherapy with PC and DC affects the subcutaneous fat, and it is theorize that the reduction of sub cutaneous fat likely follows inflammatory‐mediated necrosis and resorption.
The Use of Phosphatidylcholine for Correction of Localized Fat Deposits
  • P. Rittes
  • Medicine
    Aesthetic Plastic Surgery
  • 2003
TLDR
A clear improvement occurred in all, with a marked reduction of the fat deposits without recurrence over a 2-year follow-up period and no weight gain.
Oral polyunsaturated phosphatidylcholine reduces platelet lipid and cholesterol contents in healthy volunteers
TLDR
PPC appears to be capable of modulating lipid exchanges between cell membranes and the plasma compartment, and the most dramatic changes occurred in platelet membrane composition.
Final Report on the Safety Assessment of Lecithin and Hydrogenated Lecithin
  • Z. Fiume
  • Biology
    International journal of toxicology
  • 2001
TLDR
Lecithin and Hydrogenated LecithIn were generally nonirritating and nonsensitizing in animal and human skin; they may be safely used in leave-on products at concentrations up to 15%, the highest concentration tested in clinical irritation and sensitization studies; but the safety of use could not be substantiated in cosmetic products likely to be inhaled.
Reduction of hyperlipidemia with 3-sn-polyenyl-phosphatidylcholine in dialysis patients.
TLDR
This study shows that PPC is an effective antihyperlipidemic agent in dialysis patients and side effects in the PPC group were equivalent to those reported in the placebo group.
The Use of Phosphatidylcholine for Correction of Lower Lid Bulging Due to Prominent Fat Pads
  • P. Rittes
  • Medicine
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
  • 2001
TLDR
The injection of phosphatidylcholine (250 mg/5 ml) into the fat pads is a simple office procedure that may postpone or even substitute for lower eyelid blepharoplasty.
[Use of polyunsaturated phospholipids in the treatment of fat embolism].
[Clinical trial of Lipostabil in the treatment of diabetic angiopathy].
  • H. Warembourg, J. Jaillard
  • Medicine
    Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille
  • 1968